This trial is a prospective, single center, interventional study evaluating the safety and efficacy of SCT in patients with BCAS.
- Lung Disease
1 Primary · 6 Secondary · Reporting Duration: Measurement intervals: 2 weeks pre-procedure, 2 weeks post procedure, 3 months and then 6 months post intervention.
2 Treatment Groups
1 of 2
1 of 2
40 Total Participants · 2 Treatment Groups
Primary Treatment: Intervention · Has Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants has the maximum capacity of this experiment been set to?
"Affirmative. According to clinicaltrials.gov, this experiment is currently accepting participants. It was originally posted on October 25th 2021 and has since been edited on March 18th 2022. 40 individuals are needed from one site for the study's completion." - Anonymous Online Contributor
Is there an open enrollment period for this research endeavor?
"Per clinicaltrials.gov, this study is actively recruiting patients and was initially posted on October 25th 2021 with the most recent edit occurring on March 18th 2022." - Anonymous Online Contributor